持股变动声明
Turnstone Biologics(TSBX)04-17 05:45
$Turnstone Biologics(TSBX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010898 Size: 5 KB 网页链接
简介：Turnstone Biologics Corp.根据特拉华州法律成立于2018年12月13日。该公司是一家临床阶段的生物技术公司，专注于开发治疗和治愈实体瘤患者的新药。已获批准的免疫疗法代表着实体瘤治疗的重大进步，但许多患者要么没有反应，要么在最初反应后出现疾病复发。该公司认为，在这些患者中创造治疗性免疫疗法的最大挑战是，能够识别和攻击肿瘤的T细胞数量很少，而T细胞指的是肿瘤反应性T细胞。为了解决这个问题，该公司正在开创一种针对肿瘤浸润淋巴细胞的差异化方法，这是一种经过临床验证的治疗实体瘤的技术。
| 今开：2.9 | 昨收：2.88 |
| 最高：2.98 | 最低：2.82 |
| 涨停价： | 跌停价： |
| 总市值：65222240 |
Turnstone Biologics(TSBX)04-17 05:45
$Turnstone Biologics(TSBX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-010898 Size: 5 KB 网页链接
Turnstone Biologics(TSBX)05-14 05:05
$Turnstone Biologics(TSBX)$ 8-K Current report, item 2.02 Accession Number: 0000950170-24-058812 Act: 34 Size: 248 KB 网页链接
Turnstone Biologics(TSBX)04-23 04:35
$Turnstone Biologics(TSBX)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-046454 Act: 34 Size: 2 MB 网页链接
Turnstone Biologics(TSBX)06-01 04:25
$Turnstone Biologics(TSBX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-151828 Act: 34 Size: 26 KB 网页链接
Turnstone Biologics(TSBX)05-14 05:25
$Turnstone Biologics(TSBX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-058837 Act: 33 Size: 163 KB 网页链接
Turnstone Biologics(TSBX)06-06 05:05
$Turnstone Biologics(TSBX)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-069412 Act: 34 Size: 182 KB 网页链接
Turnstone Biologics(TSBX)04-16 20:55
$Turnstone Biologics(TSBX)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-097060 Act: 34 Size: 150 KB 网页链接
Turnstone Biologics(TSBX)04-29 20:25
$Turnstone Biologics(TSBX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001718 Act: 34 Size: 7 KB 网页链接
Turnstone Biologics(TSBX)04-23 04:45
$Turnstone Biologics(TSBX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-046466 Act: 34 Size: 1 MB 网页链接
Turnstone Biologics(TSBX)04-23 04:45
$Turnstone Biologics(TSBX)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-046471 Act: 34 Size: 7 MB 网页链接
观自在的悉达多2023-10-10 10:57
$Turnstone Biologics(TSBX)$ 97.90万的成交额拉升52.99%涨幅，没有发现特别的消息影响查看全文
美股滚雪球2023-08-29 10:48
TIL疗法公司$Lyell Immunopharma(LYEL)$ 的肿瘤候选药物LYL797将于2024年上半年公布一期数据，是公司价值的核心，最近JP Morgan将公司的目标价格调低至5美元。$Iovance(IOVA)$ $Turnstone Biologics(TSBX)$查看全文
牛唐2023-07-24 18:29
Biotech IPO热度回升，一周之内出现三家大额募资：$Apogee Therapeutics(APGE)$ 募资了3亿美元，$Sagimet Biosciences(SGMT)$ 募资8500万美元，$Turnstone Biologics(TSBX)$ 募资8000万美元。查看全文
$Turnstone Biologics(TSBX)$ 8-K Current report, item 5.07 Accession Number: 0000950170-24-069412 Act: 34 Size: 182 KB 网页链接
$Turnstone Biologics(TSBX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-151828 Act: 34 Size: 26 KB 网页链接
$Turnstone Biologics(TSBX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-058837 Act: 33 Size: 163 KB 网页链接
$Turnstone Biologics(TSBX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-058818 Act: 34 Size: 10 MB 网页链接
$Turnstone Biologics(TSBX)$ 8-K Current report, item 2.02 Accession Number: 0000950170-24-058812 Act: 34 Size: 248 KB 网页链接
$Turnstone Biologics(TSBX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001718 Act: 34 Size: 7 KB 网页链接
$Turnstone Biologics(TSBX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-046466 Act: 34 Size: 1 MB 网页链接
$Turnstone Biologics(TSBX)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-046471 Act: 34 Size: 7 MB 网页链接
$Turnstone Biologics(TSBX)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-046454 Act: 34 Size: 2 MB 网页链接
$Turnstone Biologics(TSBX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-010896 Size: 8 KB 网页链接